2-[4-acridin-2-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]acridine;8-[4-benzo[g]quinolin-8-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoline;7-[4-benzo[g]quinoxalin-7-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoxaline

C187H109N17 — CID 158963319

IUPAC2-[4-acridin-2-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]acridine;8-[4-benzo[g]quinolin-8-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoline;7-[4-benzo[g]quinoxalin-7-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoxaline
SMILESc1ccc2cc3cc(-c4cc(-c5ccc6cc7ccccc7cc6c5)cc(-c5nc(-c6ccc7cc8cccnc8cc7c6)nc(-c6ccc7cc8cccnc8cc7c6)n5)c4)ccc3cc2c1.c1ccc2cc3cc(-c4cc(-c5ccc6cc7ccccc7cc6c5)cc(-c5nc(-c6ccc7cc8nccnc8cc7c6)nc(-c6ccc7cc8nccnc8cc7c6)n5)c4)ccc3cc2c1.c1ccc2cc3cc(-c4cc(-c5ccc6cc7ccccc7cc6c5)cc(-c5nc(-c6ccc7nc8ccccc8cc7c6)nc(-c6ccc7nc8ccccc8cc7c6)n5)c4)ccc3cc2c1
InChIInChI=1S/2C63H37N5.C61H35N7/c1-3-11-40-27-50-29-44(19-17-42(50)25-38(40)9-1)52-35-53(45-20-18-43-26-39-10-2-4-12-41(39)28-51(43)30-45)37-56(36-52)63-67-61(48-21-23-59-54(33-48)31-46-13-5-7-15-57(46)64-59)66-62(68-63)49-22-24-60-55(34-49)32-47-14-6-8-16-58(47)65-60;1-3-9-40-27-52-29-46(15-13-42(52)23-38(40)7-1)54-33-55(47-16-14-43-24-39-8-2-4-10-41(39)28-53(43)30-47)35-58(34-54)63-67-61(50-19-17-44-25-48-11-5-21-64-59(48)36-56(44)31-50)66-62(68-63)51-20-18-45-26-49-12-6-22-65-60(49)37-57(45)32-51;1-3-7-38-23-48-25-42(11-9-40(48)21-36(38)5-1)50-29-51(43-12-10-41-22-37-6-2-4-8-39(37)24-49(41)26-43)31-54(30-50)61-67-59(46-15-13-44-32-55-57(34-52(44)27-46)64-19-17-62-55)66-60(68-61)47-16-14-45-33-56-58(35-53(45)28-47)65-20-18-63-56/h2*1-37H;1-35H
InChIKeyJMWUSVIXBQXNKW-UHFFFAOYSA-N
MW2594.05 g/mol
LogP47.46
Rot. Bonds15

About 2-[4-acridin-2-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]acridine;8-[4-benzo[g]quinolin-8-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoline;7-[4-benzo[g]quinoxalin-7-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoxaline

2-[4-acridin-2-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]acridine;8-[4-benzo[g]quinolin-8-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoline;7-[4-benzo[g]quinoxalin-7-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoxaline (PubChem CID 158963319) has the molecular formula C187H109N17 and a molecular weight of 2594.05 g/mol. Its IUPAC name is 2-[4-acridin-2-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]acridine;8-[4-benzo[g]quinolin-8-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoline;7-[4-benzo[g]quinoxalin-7-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoxaline.

Molecular Properties

Compound Name2-[4-acridin-2-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]acridine;8-[4-benzo[g]quinolin-8-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoline;7-[4-benzo[g]quinoxalin-7-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoxaline
PubChem CID158963319
Molecular FormulaC187H109N17
Molecular Weight2594.05 g/mol
Exact Mass2591.91
IUPAC Name2-[4-acridin-2-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]acridine;8-[4-benzo[g]quinolin-8-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoline;7-[4-benzo[g]quinoxalin-7-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoxaline
SMILESc1ccc2cc3cc(-c4cc(-c5ccc6cc7ccccc7cc6c5)cc(-c5nc(-c6ccc7cc8cccnc8cc7c6)nc(-c6ccc7cc8cccnc8cc7c6)n5)c4)ccc3cc2c1.c1ccc2cc3cc(-c4cc(-c5ccc6cc7ccccc7cc6c5)cc(-c5nc(-c6ccc7cc8nccnc8cc7c6)nc(-c6ccc7cc8nccnc8cc7c6)n5)c4)ccc3cc2c1.c1ccc2cc3cc(-c4cc(-c5ccc6cc7ccccc7cc6c5)cc(-c5nc(-c6ccc7nc8ccccc8cc7c6)nc(-c6ccc7nc8ccccc8cc7c6)n5)c4)ccc3cc2c1
InChIInChI=1S/2C63H37N5.C61H35N7/c1-3-11-40-27-50-29-44(19-17-42(50)25-38(40)9-1)52-35-53(45-20-18-43-26-39-10-2-4-12-41(39)28-51(43)30-45)37-56(36-52)63-67-61(48-21-23-59-54(33-48)31-46-13-5-7-15-57(46)64-59)66-62(68-63)49-22-24-60-55(34-49)32-47-14-6-8-16-58(47)65-60;1-3-9-40-27-52-29-46(15-13-42(52)23-38(40)7-1)54-33-55(47-16-14-43-24-39-8-2-4-10-41(39)28-53(43)30-47)35-58(34-54)63-67-61(50-19-17-44-25-48-11-5-21-64-59(48)36-56(44)31-50)66-62(68-63)51-20-18-45-26-49-12-6-22-65-60(49)37-57(45)32-51;1-3-7-38-23-48-25-42(11-9-40(48)21-36(38)5-1)50-29-51(43-12-10-41-22-37-6-2-4-8-39(37)24-49(41)26-43)31-54(30-50)61-67-59(46-15-13-44-32-55-57(34-52(44)27-46)64-19-17-62-55)66-60(68-61)47-16-14-45-33-56-58(35-53(45)28-47)65-20-18-63-56/h2*1-37H;1-35H
InChIKeyJMWUSVIXBQXNKW-UHFFFAOYSA-N
XLogP47.46
TPSA219.13 Ų
H-Bond Donors
H-Bond Acceptors17
Rotatable Bonds15
Heavy Atoms204
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002594.05
LogP ≤ 547.46
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1017

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Polycyclic_aromatic_hydrocarbon_2', 'substructure': 'N/A'}

Analyze 2-[4-acridin-2-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]acridine;8-[4-benzo[g]quinolin-8-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoline;7-[4-benzo[g]quinoxalin-7-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoxaline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-[4-[3,5-di(anthracen-2-yl)phenyl]-6-phenyl-1,3,5-triazin-2-yl]acridine;8-[4-[3,5-di(anthracen-2-yl)phenyl]-6-phenyl-1,3,5-triazin-2-yl]benzo[g]quinoline;7-[4-[3,5-di(anthracen-2-yl)phenyl]-6-phenyl-1,3,5-triazin-2-yl]benzo[g]quinoxaline
CID 159939622
6-[4-[4,6-bis(4-anthracen-2-ylphenyl)-1,3,5-triazin-2-yl]phenyl]quinoline
CID 154599225
7-[4-[3,5-di(anthracen-9-yl)phenyl]-6-phenyl-1,3,5-triazin-2-yl]benzo[g]quinoline
CID 153466132
2-[3,5-di(anthracen-2-yl)phenyl]-4,6-dipyridin-2-yl-1,3,5-triazine;2-[3,5-di(anthracen-2-yl)phenyl]-4,6-dipyridin-4-yl-1,3,5-triazine;6-[4-[3,5-di(anthracen-2-yl)phenyl]-6-quinolin-6-yl-1,3,5-triazin-2-yl]quinoline
CID 158091241
6-[4,6-bis(4-anthracen-2-ylphenyl)pyrimidin-2-yl]quinoline
CID 154599222
5-[3-[4,6-bis(benzo[g]quinolin-7-yl)-1,3,5-triazin-2-yl]-5-pyrido[2,3-g]quinolin-5-ylphenyl]pyrido[2,3-g]quinoline
CID 153466259
7-[3-[4,6-bis(3,5-diphenylphenyl)-1,3,5-triazin-2-yl]-5-quinolin-7-ylphenyl]quinoline
CID 122415943
7-[3-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-quinolin-7-ylphenyl]quinoline
CID 118582329
3-[4-[4,6-di(quinolin-6-yl)-1,3,5-triazin-2-yl]phenyl]quinoline
CID 122426517
2-[3,5-bis(4-pyrimidin-2-ylphenyl)phenyl]-4,6-dinaphthalen-2-yl-1,3,5-triazine
CID 58382639
2-(3,5-dipyridin-2-ylphenyl)-4,6-dinaphthalen-2-yl-1,3,5-triazine
CID 118582331
5-[3-[4,6-di(quinolin-3-yl)-1,3,5-triazin-2-yl]-5-pyrido[2,3-g]quinolin-5-ylphenyl]pyrido[2,3-g]quinoline;5-[3-[4,6-di(quinolin-6-yl)-1,3,5-triazin-2-yl]-5-pyrido[2,3-g]quinolin-5-ylphenyl]pyrido[2,3-g]quinoline;5-[3-[4,6-di(quinolin-7-yl)-1,3,5-triazin-2-yl]-5-pyrido[2,3-g]quinolin-5-ylphenyl]pyrido[2,3-g]quinoline
CID 162099550

Frequently Asked Questions

What is the IUPAC name of 2-[4-acridin-2-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]acridine;8-[4-benzo[g]quinolin-8-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoline;7-[4-benzo[g]quinoxalin-7-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoxaline?
The IUPAC name of 2-[4-acridin-2-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]acridine;8-[4-benzo[g]quinolin-8-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoline;7-[4-benzo[g]quinoxalin-7-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoxaline (CID 158963319) is 2-[4-acridin-2-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]acridine;8-[4-benzo[g]quinolin-8-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoline;7-[4-benzo[g]quinoxalin-7-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoxaline.
What is the SMILES notation for 2-[4-acridin-2-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]acridine;8-[4-benzo[g]quinolin-8-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoline;7-[4-benzo[g]quinoxalin-7-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoxaline?
The canonical SMILES for 2-[4-acridin-2-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]acridine;8-[4-benzo[g]quinolin-8-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoline;7-[4-benzo[g]quinoxalin-7-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoxaline is c1ccc2cc3cc(-c4cc(-c5ccc6cc7ccccc7cc6c5)cc(-c5nc(-c6ccc7cc8cccnc8cc7c6)nc(-c6ccc7cc8cccnc8cc7c6)n5)c4)ccc3cc2c1.c1ccc2cc3cc(-c4cc(-c5ccc6cc7ccccc7cc6c5)cc(-c5nc(-c6ccc7cc8nccnc8cc7c6)nc(-c6ccc7cc8nccnc8cc7c6)n5)c4)ccc3cc2c1.c1ccc2cc3cc(-c4cc(-c5ccc6cc7ccccc7cc6c5)cc(-c5nc(-c6ccc7nc8ccccc8cc7c6)nc(-c6ccc7nc8ccccc8cc7c6)n5)c4)ccc3cc2c1.
What is the InChIKey of 2-[4-acridin-2-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]acridine;8-[4-benzo[g]quinolin-8-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoline;7-[4-benzo[g]quinoxalin-7-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoxaline?
The InChIKey is JMWUSVIXBQXNKW-UHFFFAOYSA-N. The full InChI is InChI=1S/2C63H37N5.C61H35N7/c1-3-11-40-27-50-29-44(19-17-42(50)25-38(40)9-1)52-35-53(45-20-18-43-26-39-10-2-4-12-41(39)28-51(43)30-45)37-56(36-52)63-67-61(48-21-23-59-54(33-48)31-46-13-5-7-15-57(46)64-59)66-62(68-63)49-22-24-60-55(34-49)32-47-14-6-8-16-58(47)65-60;1-3-9-40-27-52-29-46(15-13-42(52)23-38(40)7-1)54-33-55(47-16-14-43-24-39-8-2-4-10-41(39)28-53(43)30-47)35-58(34-54)63-67-61(50-19-17-44-25-48-11-5-21-64-59(48)36-56(44)31-50)66-62(68-63)51-20-18-45-26-49-12-6-22-65-60(49)37-57(45)32-51;1-3-7-38-23-48-25-42(11-9-40(48)21-36(38)5-1)50-29-51(43-12-10-41-22-37-6-2-4-8-39(37)24-49(41)26-43)31-54(30-50)61-67-59(46-15-13-44-32-55-57(34-52(44)27-46)64-19-17-62-55)66-60(68-61)47-16-14-45-33-56-58(35-53(45)28-47)65-20-18-63-56/h2*1-37H;1-35H.
What are the key properties of 2-[4-acridin-2-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]acridine;8-[4-benzo[g]quinolin-8-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoline;7-[4-benzo[g]quinoxalin-7-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoxaline?
2-[4-acridin-2-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]acridine;8-[4-benzo[g]quinolin-8-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoline;7-[4-benzo[g]quinoxalin-7-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoxaline has a molecular weight of 2594.05 g/mol, XLogP of 47.46, 15 rotatable bonds, 0 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-acridin-2-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]acridine;8-[4-benzo[g]quinolin-8-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoline;7-[4-benzo[g]quinoxalin-7-yl-6-[3,5-di(anthracen-2-yl)phenyl]-1,3,5-triazin-2-yl]benzo[g]quinoxaline is sourced from PubChem (CID 158963319), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).